150 related articles for article (PubMed ID: 27606620)
21. Bone stroma-derived cells change coregulators recruitment to androgen receptor and decrease cell proliferation in androgen-sensitive and castration-resistant prostate cancer cells.
Villagran MA; Gutierrez-Castro FA; Pantoja DF; Alarcon JC; Fariña MA; Amigo RF; Muñoz-Godoy NA; Pinilla MG; Peña EA; Gonzalez-Chavarria I; Toledo JR; Rivas CI; Vera JC; McNerney EM; Onate SA
Biochem Biophys Res Commun; 2015 Nov; 467(4):1039-45. PubMed ID: 26494300
[TBL] [Abstract][Full Text] [Related]
22. Melanoma antigen gene protein-A11 (MAGE-11) F-box links the androgen receptor NH2-terminal transactivation domain to p160 coactivators.
Askew EB; Bai S; Hnat AT; Minges JT; Wilson EM
J Biol Chem; 2009 Dec; 284(50):34793-808. PubMed ID: 19828458
[TBL] [Abstract][Full Text] [Related]
23. A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation.
Wong HY; Hoogerbrugge JW; Pang KL; van Leeuwen M; van Royen ME; Molier M; Berrevoets CA; Dooijes D; Dubbink HJ; van de Wijngaart DJ; Wolffenbuttel KP; Trapman J; Kleijer WJ; Drop SL; Grootegoed JA; Brinkmann AO
Mol Cell Endocrinol; 2008 Sep; 292(1-2):69-78. PubMed ID: 18656523
[TBL] [Abstract][Full Text] [Related]
24. Roles of steroid receptor coactivator (SRC)-1 and transcriptional intermediary factor (TIF) 2 in androgen receptor activity in mice.
Ye X; Han SJ; Tsai SY; DeMayo FJ; Xu J; Tsai MJ; O'Malley BW
Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9487-92. PubMed ID: 15983373
[TBL] [Abstract][Full Text] [Related]
25. Expression and function of androgen receptor coactivators in prostate cancer.
Culig Z; Comuzzi B; Steiner H; Bartsch G; Hobisch A
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):265-71. PubMed ID: 15663989
[TBL] [Abstract][Full Text] [Related]
26. Protein kinase A (PKA) pathway is functionally linked to androgen receptor (AR) in the progression of prostate cancer.
Sarwar M; Sandberg S; Abrahamsson PA; Persson JL
Urol Oncol; 2014 Jan; 32(1):25.e1-12. PubMed ID: 23410945
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of p160 steroid receptor coactivators in the rat testis and epididymis.
Igarashi-Migitaka J; Takeshita A; Koibuchi N; Yamada S; Ohtani-Kaneko R; Hirata K
Eur J Endocrinol; 2005 Oct; 153(4):595-604. PubMed ID: 16189181
[TBL] [Abstract][Full Text] [Related]
28. Interaction between docetaxel resistance and castration resistance in prostate cancer: implications of Twist1, YB-1, and androgen receptor.
Shiota M; Kashiwagi E; Yokomizo A; Takeuchi A; Dejima T; Song Y; Tatsugami K; Inokuchi J; Uchiumi T; Naito S
Prostate; 2013 Sep; 73(12):1336-44. PubMed ID: 23775496
[TBL] [Abstract][Full Text] [Related]
29. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.
McGrath MJ; Binge LC; Sriratana A; Wang H; Robinson PA; Pook D; Fedele CG; Brown S; Dyson JM; Cottle DL; Cowling BS; Niranjan B; Risbridger GP; Mitchell CA
Cancer Res; 2013 Aug; 73(16):5066-79. PubMed ID: 23801747
[TBL] [Abstract][Full Text] [Related]
31. Poly (A) Binding Protein Cytoplasmic 1 Is a Novel Co-Regulator of the Androgen Receptor.
Eisermann K; Dar JA; Dong J; Wang D; Masoodi KZ; Wang Z
PLoS One; 2015; 10(7):e0128495. PubMed ID: 26176602
[TBL] [Abstract][Full Text] [Related]
32. PRMT2, a member of the protein arginine methyltransferase family, is a coactivator of the androgen receptor.
Meyer R; Wolf SS; Obendorf M
J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):1-14. PubMed ID: 17587566
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of the androgen receptor and its coactivators in patients with D1 prostate cancer.
Mori R; Wang Q; Quek ML; Tarabolous C; Cheung E; Ye W; Groshen S; Hawes D; Togo S; Shimada H; Danenberg KD; Danenberg PV; Pinski JK
Anticancer Res; 2008; 28(1B):425-30. PubMed ID: 18383880
[TBL] [Abstract][Full Text] [Related]
34. Endostatin: A novel inhibitor of androgen receptor function in prostate cancer.
Lee JH; Isayeva T; Larson MR; Sawant A; Cha HR; Chanda D; Chesnokov IN; Ponnazhagan S
Proc Natl Acad Sci U S A; 2015 Feb; 112(5):1392-7. PubMed ID: 25605930
[TBL] [Abstract][Full Text] [Related]
35. High-Throughput Screen for Inhibitors of Androgen Receptor-RUNX2 Transcriptional Regulation in Prostate Cancer.
Vuong W; Tew BY; Little GH; Frenkel B; Jones JO
J Pharmacol Exp Ther; 2016 Nov; 359(2):256-261. PubMed ID: 27554677
[TBL] [Abstract][Full Text] [Related]
36. Androgen ablation elicits PP1-dependence for AR stabilization and transactivation in prostate cancer.
Liu X; Han W; Gulla S; Simon NI; Gao Y; Liu J; Wang L; Yang H; Zhang X; Chen S
Prostate; 2016 May; 76(7):649-61. PubMed ID: 26847655
[TBL] [Abstract][Full Text] [Related]
37. Quantitative detection of the ligand-dependent interaction between the androgen receptor and the co-activator, Tif2, in live cells using two color, two photon fluorescence cross-correlation spectroscopy.
Rosales T; Georget V; Malide D; Smirnov A; Xu J; Combs C; Knutson JR; Nicolas JC; Royer CA
Eur Biophys J; 2007 Feb; 36(2):153-61. PubMed ID: 17021805
[TBL] [Abstract][Full Text] [Related]
38. Splicing Factor Prp8 Interacts With NES(AR) and Regulates Androgen Receptor in Prostate Cancer Cells.
Wang D; Nguyen MM; Masoodi KZ; Singh P; Jing Y; O'Malley K; Dar JA; Dhir R; Wang Z
Mol Endocrinol; 2015 Dec; 29(12):1731-42. PubMed ID: 26371515
[TBL] [Abstract][Full Text] [Related]
39. Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes.
Olsen JR; Azeem W; Hellem MR; Marvyin K; Hua Y; Qu Y; Li L; Lin B; Ke X; Øyan AM; Kalland K
BMC Cancer; 2016 Jul; 16():377. PubMed ID: 27378372
[TBL] [Abstract][Full Text] [Related]
40. Acquisition of agonistic properties of nonsteroidal antiandrogens after treatment with oncostatin M in prostate cancer cells.
Godoy-Tundidor S; Hobisch A; Pfeil K; Bartsch G; Culig Z
Clin Cancer Res; 2002 Jul; 8(7):2356-61. PubMed ID: 12114440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
